Opinion

Why the FDA was wrong to delay authorization of vaccines for kids under 5

Govind Persad is assistant professor at the University of Denver Sturm College of Law. Alyssa Burgart is an associate professor of pediatric anesthesiology at Stanford University. Emily Largent is an assistant professor at the University of Pennsylvania Perelman School of Medicine.

The Food and Drug Administration made the wrong call when it announced last week that it will delay authorization of the Pfizer-BioNTech vaccine for children under 5.